logo BLUE BI business intelligence & analytics

Digital Dashboard: data drives digital business investments

Share

CASE STUDY | ANGELINI PHARMA

NEW NEEDS FOR PHARMA INDUSTRY

In the pharmaceutical industry, a deep digitalization process is underway that has prompted organizations to review their business strategies and adopt an increasingly data-oriented approach.

The context in which Angelini Pharma was, before undertaking this project, prevented Digital Managers from evaluating investments in the digital world, and the lack of consolidated data made it difficult to understand the effectiveness of global campaigns and the actual achievement of objectives.

Discover how Blue BI supported Angelini Pharma in the implementation of a Digital Dashboard that, to date, it is used by 86% of enabled users and is the first tool to monitor the performance of multichannel activities and guide strategic business decisions.

PAIN POINTS

CENTRAL HUB

Need to have a unique and shared analysis tool
READ MORE

ACCESSIBILITY

Need to make data accessible to all key actors in the project 
READ MORE

IN-DEPTH DATA ANALYSIS

Data deepening and detailed analyses that can be exported to Excel
READ MORE

OMNICHANNEL VISION

Full and detailed perspective of digital activities targeted at HCPs
READ MORE

The customer's voice

We needed data to understand how investments were going in the digital world. Blue BI has proved to be a reliable partner and has proactively followed us from the early embryonic stages of the project, to design with the country, until its implementation. Today, the Digital Dashboard is the reference point for the activities of our digital channels and allows us to provide a better service to our HCPs.
Francesco Iaccarino
Demand Manager Commercial Operations & HR

READ THE FULL CASE STUDY

Authors:
,

Table of Contents